Tag: Schizophrenia
-
![Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia [2012 Double Blind Randomized Study]](https://weedpress.org/wp-content/uploads/2019/11/smoke.jpg?w=201)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia [2012 Double Blind Randomized Study]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/ Transl Psychiatry. 2012 Mar; 2(3): e94. Published online 2012 Mar 20. doi: 10.1038/tp.2012.15 PMCID: PMC3316151 PMID: 22832859 Abstract Cannabidiol is a component of marijuana that does not activate cannabinoid receptors, but moderately inhibits the degradation of the endocannabinoid anandamide. We previously reported that an elevation of anandamide levels in cerebrospinal fluid inversely correlated to psychotic…
-
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Title: Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia Author: F M Leweke, D Piomelli, F Pahlisch, D Muhl, C W Gerth et al. Publication: Translational Psychiatry Publisher: Springer Nature Date: Mar 20, 2012 Copyright © 2012, Springer Nature https://www.nature.com/articles/tp201215 Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia F M…
-
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2017.17030325 Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial Philip McGuire , F.R.C.Psych., F.Med.Sci., Philip Robson , M.R.C.P., F.R.C.Psych., Wieslaw Jerzy Cubala , M.D., Ph.D., Daniel Vasile , M.D., Ph.D., Paul Dugald Morrison , Ph.D., M.R.C.Psych., Rachel Barron , B.Vet.Med., M.R.C.V.S., Adam Taylor , Ph.D., Stephen Wright , F.R.C.P.(Edin), F.F.P.M.…
-
Case Report: Daily CBD Administration Associated With Remission Of Schizophrenic Symptoms
Arresting the mentally ill for educated and informed self-medicating is unconscionable when they’re only seeking SAFE relief unlike those nasty pharma meds. From https://norml.org/news/2018/12/20/case-report-daily-cbd-administration-associated-with-remission-of-schizophrenic-symptoms Thursday, 20 December 2018 Leipzig, Germany: The adjunctive use of cannabidiol is associated with a remission in schizophrenic symptoms in a patient previously unresponsive to conventional treatment, according to a case…
-
Here’s the full study from the Harm Reduction Journal On Cannabis Using Patients With Schizophrenia
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia Jan van AmsterdamEmail authorView ORCID ID profile, Jojanneke Vervloet, Gerdien de Weert, Victor J. A. Buwalda, Anna E. Goudriaan and Wim van den Brink Harm Reduction Journal201815:47 https://doi.org/10.1186/s12954-018-0253-7 © The Author(s). 2018 Received: 5 June 2018 Accepted: 4 September 2018 Published: 20 September 2018 Abstract Background Cannabis-smoking patients with a psychotic disorder have poorer disease outcomes than non-cannabis-smoking patients with…
-
Harm Reduction Journal: Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
Excerpted from this Psychedelic Times article: A study recently published in Harm Reduction Journal investigated whether patients with a psychotic disorder would accept smoking pharmaceutical cannabis variants that are less harmful than high-potency cannabis. Results There were very few undesired side effects from smoking the joints in the study. Psychotic-like symptoms were not observed…
WeedPress: The Paper Trail 